Pharmaceutical Market Europe • January 2023 • 5
CONTENTS
January 2023
NEWS & COLUMNS
6-7 NEWS
Amgen to acquire Horizon for $27.8bn; Takeda to acquire Nimbus’ TYK2 inhibitor in deal worth $6bn
8-9 NEWS
Merck and Moderna develop personalised cancer vaccine; EC approves Takeda’s dengue vaccine
10-11 CORONAVIRUS NEWS
WHO member states to produce pandemic accord; Pfizer and Clear Creek work on COVID-19 research
12 DARWIN'S MEDICINE
Why microfoundations matter
13 POLICY AND PUBLIC HEALTH
US experts suggest screening adults for anxiety
14 NEW YEAR'S RESOLUTIONS
Making 2023 a better year for yourself and others
15 PHARMA STRATEGIST'S BLOG
The lost art of the brand narrative
FEATURES
16-17 ASH 2022: DRIVING CHANGE IN HAEMATOLOGY
Five trends from this year’s ASH conference – and why even pop icons can’t compete with the playlist of innovation shaping haematology
18-19 THE CHALLENGES OF IDENTIFYING RARE DISEASES
With increased awareness and improved diagnosis, more rare diseases are being recognised and that number is likely to increase
22-23 CELLTRION'S CEO TALKS ABOUT IMPROVING PATIENT OUTCOMES WITH BIOSIMILARS
How Europe’s biosimilar landscape has rapidly evolved over the last two decades, bringing biological medicines to more patients than ever before
COMMUNIQUE
MARKETING & COMMS
26-27 MEETING HEALTHCARE’S RISING CHALLENGES
Using digital innovation to discover novel therapies and ensure scientific advances achieve their potential
30-31 STRATEGIC BEHAVIOUR
The impact of behavioural issues and the key to developing the most effective strategies
32-33 FLYPHARMA MIDDLE EAST
The new event will be supported by the Department of Culture and Tourism – Abu Dhabi (DCT Abu Dhabi), the Department of Health – Abu Dhabi and Etihad Cargo
37 HEALTHCARE COMMS
Inizio acquires Evolution Road; imc Group rebrands as SCIRIS
CAREERS & RECRUITMENT
34-36 APPOINTMENTS
Changes at AstraZeneca, Incyte and Lumanity
39 PHARMA MARKETING JOBS
New website coming soon!